Improved pasireotide response in USP8 mutant corticotroph tumours in vitro.

MLA

Albani, Adriana, et al. “Improved Pasireotide Response in USP8 Mutant Corticotroph Tumours in Vitro.” Endocrine-Related Cancer, vol. 29, no. 8, June 2022, pp. 503–11. EBSCOhost, https://doi.org/10.1530/ERC-22-0088.

APA

Albani, A., Perez-Rivas, L. G., Tang, S., Simon, J., Lucia, K. E., Colón-Bolea, P., Schopohl, J., Roeber, S., Buchfelder, M., Rotermund, R., Flitsch, J., Thorsteinsdottir, J., Herms, J., Stalla, G., Reincke, M., & Theodoropoulou, M. (2022). Improved pasireotide response in USP8 mutant corticotroph tumours in vitro. Endocrine-Related Cancer, 29(8), 503–511. https://doi.org/10.1530/ERC-22-0088

Chicago

Albani, Adriana, Luis Gustavo Perez-Rivas, Sicheng Tang, Julia Simon, Kristin Elisabeth Lucia, Paula Colón-Bolea, Jochen Schopohl, et al. 2022. “Improved Pasireotide Response in USP8 Mutant Corticotroph Tumours in Vitro.” Endocrine-Related Cancer 29 (8): 503–11. doi:10.1530/ERC-22-0088.